Skip to main content
Premium Trial:

Request an Annual Quote

Dyadic Taps Agencourt to Sequence C. lucknowense Fungus

NEW YORK, Feb. 17 (GenomeWeb News) - Dyadic International has chosen Agencourt Bioscience to sequence the genome of its Chrysosporium lucknowense fungus, the company said yesterday.

 

Dyadic will use the data to maximize the utility of its Host Technology for the organism, also known as C1. The company said the Host Technology business "forms a cornerstone" of its Enzymes and Biosciences units.

 

Financial details of the agreement were not disclosed.

To date, Dyadic scientists have characterized approximately 30 C1 genes, the company said. With Agencourt's help, the firm "expect[s] to identify up to 12,000 genes" in the C1 genome, including genes for potential new protein and enzyme products.

 

Agencourt, an NHGRI-designated Large Scale Sequencing Center, will conduct all phases of the sequencing project, including construction of multiple libraries, high throughput sequencing, assembly, and finishing, Dyadic said.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.